Page last updated: 2024-10-16

adenine and Fungal Diseases

adenine has been researched along with Fungal Diseases in 8 studies

Research

Studies (8)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (25.00)24.3611
2020's6 (75.00)2.80

Authors

AuthorsStudies
Davis, MR1
Thompson, GR1
Patterson, TF1
Luppi, M1
Forghieri, F1
Potenza, L1
Anastasopoulou, A1
DiPippo, AJ2
Kontoyiannis, DP2
Frei, M1
Aitken, SL1
Jain, N1
Thompson, P1
Wierda, W1
Reynolds, G1
Slavin, M1
Teh, BW2
Kaloyannidis, P1
Ayyad, A1
Bahaliwah, Z1
Blowi, B1
Alanazi, W1
Al Shammasi, Z1
Elsoudi, H1
Ibrahim, I1
Al Hashmi, H1
Chui, W1
Handunnetti, S1
Tam, C1
Worth, LJ1
Thursky, KA1
Slavin, MA1
Kabbage, M1
Williams, B1
Dickman, MB1

Reviews

2 reviews available for adenine and Fungal Diseases

ArticleYear
Fungal Infections Potentiated by Biologics.
    Infectious disease clinics of North America, 2020, Volume: 34, Issue:2

    Topics: Adenine; Antigens, CD; Biological Products; Clinical Trials as Topic; Humans; Mycoses; Piperidines;

2020
Non-Aspergillus invasive mould infections in patients treated with ibrutinib.
    Mycoses, 2020, Volume: 63, Issue:8

    Topics: Adenine; Aged; Anticarcinogenic Agents; Antifungal Agents; Aspergillosis; Aspergillus; Female; Fungi

2020

Other Studies

6 other studies available for adenine and Fungal Diseases

ArticleYear
Ibrutinib Is a Newly Recognized Host Factor for the Definition of Probable Invasive Pulmonary Mold Disease, Based on Off-target Effects, Unrelated to Its B-cell Immunosuppressant Activity.
    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2020, 12-15, Volume: 71, Issue:12

    Topics: Adenine; B-Lymphocytes; Consensus; Humans; Immunosuppressive Agents; Mycoses; Neoplasms; Piperidines

2020
Incidence and characterization of fungal infections in chronic lymphocytic leukemia patients receiving ibrutinib.
    Leukemia & lymphoma, 2020, Volume: 61, Issue:10

    Topics: Adenine; Humans; Incidence; Leukemia, Lymphocytic, Chronic, B-Cell; Mycoses; Piperidines; Pyrazoles

2020
Ibrutinib and invasive fungal infections: the known, the unknown and the known unknowns.
    Leukemia & lymphoma, 2020, Volume: 61, Issue:10

    Topics: Adenine; Humans; Incidence; Invasive Fungal Infections; Leukemia, Lymphocytic, Chronic, B-Cell; Myco

2020
Ibrutinib for steroid refractory chronic graft-versus-host disease: therapeutic efficiency can be limited by increased risk of fungal infection.
    Bone marrow transplantation, 2021, Volume: 56, Issue:8

    Topics: Adenine; Chronic Disease; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; My

2021
High rates of proven invasive fungal disease with the use of ibrutinib monotherapy for relapsed or refractory chronic lymphocytic leukemia.
    Leukemia & lymphoma, 2019, Volume: 60, Issue:6

    Topics: Adenine; Drug Resistance, Neoplasm; Female; Humans; Leukemia, Lymphocytic, Chronic, B-Cell; Male; My

2019
Cell death control: the interplay of apoptosis and autophagy in the pathogenicity of Sclerotinia sclerotiorum.
    PLoS pathogens, 2013, Volume: 9, Issue:4

    Topics: Adenine; Androstadienes; Antifungal Agents; Apoptosis; Arabidopsis; Ascomycota; Autophagy; Chloroqui

2013